TG Therapeutics, Inc. (TGTX) by event type
TGTX moves most on analyst downgrades — a median of +0.98% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the TGTX overview →
How TGTX reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 740 of 2,717 | 12 | +0.23% | 58% | +0.74% |
| Analyst downgrades 132 of 2,603 | 10 | +0.98% | 70% | +0.47% |
| Rating reiterations 505 of 3,522 | 55 | +0.18% | 60% | 0.00% |
| Price-target raises 171 of 1,790 | 16 | +0.24% | 56% | -0.66% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how TGTX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · TGTX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OWC PHARMS RESEARCH CORP (OWCP) | 220 | +0.09% | 52% |
| PROVECTUS BIOPHARMS (PVCT) | 220 | +0.01% | 50% |
| Lipocine Inc. (LPCN) | 219 | +0.34% | 52% |
| Mettler-Toledo International, Inc. (MTD) | 219 | -0.10% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.